1. Home
  2. SCPH vs LNKB Comparison

SCPH vs LNKB Comparison

Compare SCPH & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • LNKB
  • Stock Information
  • Founded
  • SCPH 2013
  • LNKB 2018
  • Country
  • SCPH United States
  • LNKB United States
  • Employees
  • SCPH N/A
  • LNKB N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • LNKB
  • Sector
  • SCPH Health Care
  • LNKB
  • Exchange
  • SCPH Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • SCPH 299.0M
  • LNKB 270.4M
  • IPO Year
  • SCPH 2017
  • LNKB N/A
  • Fundamental
  • Price
  • SCPH $5.67
  • LNKB $7.08
  • Analyst Decision
  • SCPH Buy
  • LNKB Strong Buy
  • Analyst Count
  • SCPH 3
  • LNKB 1
  • Target Price
  • SCPH $12.00
  • LNKB $9.00
  • AVG Volume (30 Days)
  • SCPH 2.0M
  • LNKB 60.5K
  • Earning Date
  • SCPH 11-12-2025
  • LNKB 10-27-2025
  • Dividend Yield
  • SCPH N/A
  • LNKB 4.26%
  • EPS Growth
  • SCPH N/A
  • LNKB N/A
  • EPS
  • SCPH N/A
  • LNKB 1.01
  • Revenue
  • SCPH $49,969,000.00
  • LNKB $121,982,000.00
  • Revenue This Year
  • SCPH $104.30
  • LNKB $18.26
  • Revenue Next Year
  • SCPH $76.06
  • LNKB N/A
  • P/E Ratio
  • SCPH N/A
  • LNKB $6.98
  • Revenue Growth
  • SCPH 107.79
  • LNKB 79.01
  • 52 Week Low
  • SCPH $1.94
  • LNKB $6.09
  • 52 Week High
  • SCPH $6.28
  • LNKB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.40
  • LNKB 45.26
  • Support Level
  • SCPH $5.64
  • LNKB $6.92
  • Resistance Level
  • SCPH $5.65
  • LNKB $7.25
  • Average True Range (ATR)
  • SCPH 0.03
  • LNKB 0.20
  • MACD
  • SCPH -0.02
  • LNKB -0.03
  • Stochastic Oscillator
  • SCPH 66.67
  • LNKB 27.87

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.

Share on Social Networks: